Differential β-Arrestin Trafficking and Endosomal Sorting of Somatostatin Receptor Subtypes
Open Access
- 1 May 2004
- journal article
- Published by Elsevier
- Vol. 279 (20), 21374-21382
- https://doi.org/10.1074/jbc.m313522200
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- The Pathophysiological Consequences of Somatostatin Receptor Internalization and ResistanceEndocrine Reviews, 2003
- Somatostatin Analog Therapy in Treatment of Gastrointestinal Disorders and TumorsEndocrine, 2003
- Identification of somatostatin receptor subtypes 1, 2A, 3, and 5 in neuroendocrine tumours with subtype specific antibodiesGut, 2002
- Preliminary data on biodistribution and dosimetry for therapy planning of somatostatin receptor positive tumours: comparison of 86Y-DOTATOC and 111In-DTPA-octreotideEuropean Journal of Nuclear Medicine and Molecular Imaging, 2001
- Cellular biology of somatostatin receptorsNeuropeptides, 2001
- Somatostatin and Its Receptor FamilyFrontiers in Neuroendocrinology, 1999
- Somatostatin receptor (SSTR) subtype-selective analogues differentially suppress in vitro growth hormone and prolactin in human pituitary adenomas. Novel potential therapy for functional pituitary tumors.Journal of Clinical Investigation, 1997
- THE PHARMACOLOGICAL ASPECTS OF THE TREATMENT OF ACROMEGALYPharmacological Research, 1996
- OctreotideNew England Journal of Medicine, 1996
- The Role of Somatostatin and Its Analogs in the Diagnosis and Treatment of TumorsEndocrine Reviews, 1991